Christopher Conn is an experienced professional in precision medicine and companion diagnostics, currently serving as the Director of Precision Medicine - Global Diagnostics Strategy at Amgen since September 2022. Prior to this role, Conn worked at AbbVie as the Scientific Director for Companion Diagnostics Strategy, overseeing global diagnostic strategies for targeted therapeutic areas. Previous positions include Principal Scientist at Amgen, Senior Manager at Array BioPharma, and various roles at QIAGEN, where Conn developed and implemented strategies for oncology companion diagnostics and personalized medicine. Educational qualifications include a Ph.D. in Cell and Molecular Biology from the University of Cincinnati College of Medicine and a B.S. in Biology from Lee University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices